Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to $5.3 million.

  • Myomo's Cost of Revenue rose 5448.29% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 7057.01%. This contributed to the annual value of $12.2 million for FY2024, which is 3532.37% up from last year.
  • Myomo's Cost of Revenue amounted to $5.3 million in Q3 2025, which was up 5448.29% from $5.2 million recorded in Q2 2025.
  • Myomo's Cost of Revenue's 5-year high stood at $5.3 million during Q3 2025, with a 5-year trough of $623152.0 in Q1 2021.
  • In the last 5 years, Myomo's Cost of Revenue had a median value of $2.3 million in 2023 and averaged $2.4 million.
  • Data for Myomo's Cost of Revenue shows a peak YoY increase of 11524.18% (in 2021) and a maximum YoY decrease of 976.15% (in 2021) over the last 5 years.
  • Myomo's Cost of Revenue (Quarter) stood at $909175.0 in 2021, then skyrocketed by 55.52% to $1.4 million in 2022, then surged by 66.43% to $2.4 million in 2023, then surged by 57.1% to $3.7 million in 2024, then skyrocketed by 42.13% to $5.3 million in 2025.
  • Its Cost of Revenue was $5.3 million in Q3 2025, compared to $5.2 million in Q2 2025 and $4.4 million in Q1 2025.